<\/p>\n
Questions About Identifying and Counseling Women at
\nIncreased Risk for Breast Cancer<\/p>\n
\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n \u00a0<\/span><\/span><\/p>\n 1. Which one \u00a0<\/span><\/p>\n a. Family history of breast b. Age at diagnosis of mother c. Family history of breast d. Family history of breast e. Family history of ovarian \u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n 2. Which one \u00a0<\/span><\/p>\n a. 1.3%<\/span><\/p>\n b. 1.7%<\/span><\/p>\n c. 2.6%<\/span><\/p>\n d. 25%<\/span><\/p>\n e. 50%<\/span><\/p>\n \u00a0<\/span><\/p>\n 3. Which one \u00a0<\/span><\/p>\n a. Is as effective as tamoxifen b. Acts as an estrogen c. Acts as an estrogen d. Is currently approved by the e. Is associated with an \u00a0<\/span><\/p>\n 4. Which one a. Tamoxifen should not be given b. Tamoxifen is the most c. Close surveillance is not an d. Prophylactic mastectomy is e. Prophylactic oophorectomy is \u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Correct 1. a<\/em>, 2 \u00a0<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":" Questions About Identifying and Counseling Women at Increased Risk for Breast Cancer \u00a0 \u00a0 \u00a0 1. Which one of the following patient characteristics is incorporated into the NCI Risk Assessment tool? \u00a0 a. Family history of breast cancer in a sister b. Age at diagnosis of mother and\/or sister affected by breast cancer c…..<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1499,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"class_list":["post-1502","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/1502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/comments?post=1502"}],"version-history":[{"count":1,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/1502\/revisions"}],"predecessor-version":[{"id":1505,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/1502\/revisions\/1505"}],"up":[{"embeddable":true,"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/pages\/1499"}],"wp:attachment":[{"href":"https:\/\/jacobimed.org\/old\/wp-json\/wp\/v2\/media?parent=1502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/em>of the following patient characteristics is incorporated <\/em>into the
\nNCI Risk Assessment tool?<\/span><\/p>\n
\ncancer in a sister<\/span><\/p>\n
\nand\/or sister affected by breast cancer<\/span><\/p>\n
\ncancer in a maternal aunt<\/span><\/p>\n
\ncancer in paternal relatives<\/span><\/p>\n
\ncancer<\/span><\/p>\n
\n<\/em>of the following percentages is correct <\/em>regarding the absolute
\nbreast cancer risk reduction after 5 years of tamoxifen administration in the
\nBreast Cancer Prevention Trial?<\/span><\/p>\n
\n<\/em>of the following regarding raloxifene is correct<\/em>?<\/span><\/p>\n
\nin short-term breast cancer risk reduction<\/span><\/p>\n
\nantagonist at the level of bone<\/span><\/p>\n
\nantagonist at the level of the breasts<\/span><\/p>\n
\nFood and Drug Administration for breast cancer risk reduction<\/span><\/p>\n
\nincreased risk of uterine cancer<\/span><\/p>\n
\n<\/em>of the following statements about breast cancer risk reduction options is correct<\/em>?<\/span><\/p>\n
\nas a chemopreventive agent to women older than 65.<\/span><\/p>\n
\neffective means of breast cancer risk reduction in women with known BRCA <\/em>mutations.<\/span><\/p>\n
\nappropriate option in women with BRCA <\/em>mutations<\/span><\/p>\n
\nassociated with a 90% reduction in the incidence of breast cancer.<\/span><\/p>\n
\nan effective means of breast cancer risk reduction in only women with BRCA <\/em>mutations.<\/span><\/p>\n
\nanswers:<\/span><\/p>\n
\na<\/em>, 3. c<\/em>, 4. d<\/em><\/span><\/p>\n